Correlation Between Cadrenal Therapeutics, and Nkarta

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Nkarta at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Nkarta into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Nkarta Inc, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Nkarta and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Nkarta. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Nkarta.

Diversification Opportunities for Cadrenal Therapeutics, and Nkarta

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Cadrenal and Nkarta is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Nkarta Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nkarta Inc and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Nkarta. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nkarta Inc has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Nkarta go up and down completely randomly.

Pair Corralation between Cadrenal Therapeutics, and Nkarta

Given the investment horizon of 90 days Cadrenal Therapeutics, Common is expected to generate 1.58 times more return on investment than Nkarta. However, Cadrenal Therapeutics, is 1.58 times more volatile than Nkarta Inc. It trades about -0.03 of its potential returns per unit of risk. Nkarta Inc is currently generating about -0.29 per unit of risk. If you would invest  1,509  in Cadrenal Therapeutics, Common on August 28, 2024 and sell it today you would lose (138.00) from holding Cadrenal Therapeutics, Common or give up 9.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Cadrenal Therapeutics, Common  vs.  Nkarta Inc

 Performance 
       Timeline  
Cadrenal Therapeutics, 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Cadrenal Therapeutics, Common are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating forward-looking signals, Cadrenal Therapeutics, exhibited solid returns over the last few months and may actually be approaching a breakup point.
Nkarta Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nkarta Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Cadrenal Therapeutics, and Nkarta Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cadrenal Therapeutics, and Nkarta

The main advantage of trading using opposite Cadrenal Therapeutics, and Nkarta positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Nkarta can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nkarta will offset losses from the drop in Nkarta's long position.
The idea behind Cadrenal Therapeutics, Common and Nkarta Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals